{"entity":{"id":"fda-ghana","kind":"institution","name":"Food and Drugs Authority, Ghana (FDA Ghana)","aka":["FDA Ghana","Ghana FDA","Food and Drugs Board, Ghana"],"tldr":"Ghana's medicines regulator. WHO reported in May 2020 that it had reached maturity level 3 for medicines, making Ghana the second country in the WHO African Region to do so, and its clinical trials function reached maturity level 4 in July 2024.","summary":"The Food and Drugs Board was established by the Food and Drugs Law 1992 (PNDCL 305B); its first board was inaugurated on 26 August 1997, and it became the Food and Drugs Authority under the Public Health Act 2012 (Act 851). It registers medicines, licenses facilities and authorises clinical trials. The coordinates are an approximate Accra city point.\n\nWHO's feature of 13 May 2020 says Ghana became the second country in the WHO African Region, after Tanzania in November 2018, to reach maturity level 3, the second-highest of WHO's four levels, after Global Benchmarking Tool evaluations in 2014, 2015 and 2019. The Authority's clinical trials page states that its Clinical Trials Function attained maturity level 4 in clinical trials oversight in July 2024, which it describes as a first for a regulator in Africa.\n\nUnder Part 8 of Act 851 no clinical trial of a drug, herbal medicinal product, cosmetic, medical device or procedure may run without the Authority's certificate, issued after ethics committee approval. An application must include proof of registration with the Pan African Clinical Trials Registry, and for a trial already approved by a well-resourced regulator the Authority can use a reliance pathway based on that regulator's full assessment reports. Summaries of its reviews are published as public assessment reports.","asOf":"2026-11-11","links":[{"label":"FDA Ghana: history","url":"https://fdaghana.gov.gh/history/"},{"label":"FDA Ghana: clinical trials authorization","url":"https://fdaghana.gov.gh/services-2/clinical-trials-authorization-service/"},{"label":"WHO: Ghana bolsters medicines regulatory system, guarantees product quality (13 May 2020)","url":"https://www.who.int/news-room/feature-stories/detail/ghana-bolsters-medicines-regulatory-system-guarantees-product-quality"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":["ghana-ministry-of-health","who"],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Accra","country":"GH","lat":5.6,"lng":-0.17,"institutionType":"government","website":"https://fdaghana.gov.gh","programs":["Marketing authorisation of medicines","Clinical trial authorisation (Public Health Act 2012, Part 8)","Reliance pathway for clinical trials","Public assessment reports","Pharmacovigilance (Safety Watch)"]},"route":"/institutions/fda-ghana/","neighbours":{"institution":[{"id":"ghana-ministry-of-health","kind":"institution","name":"Ministry of Health, Ghana","route":"/institutions/ghana-ministry-of-health/"},{"id":"who","kind":"institution","name":"World Health Organization Cancer Programme","route":"/institutions/who/"}]}}